ASPEN AEROGELS INC ASPN Cash Flow

Aspen aerogels inc (ASPN)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14
Cash flows from operating activities:
Net loss
-11,732	-14,565	-27,717	-31,960	-33,600	-34,440	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-19,304	-	-4,643	-4,069	-5,424	-6,417	-10,772	-10,660	-50,065	-66,324	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
10,244	10,213	10,179	10,198	10,148	10,787	10,980	11,133	11,248	10,753	10,587	10,333	10,119	9,853	9,763	9,954	10,113	9,887	9,913	9,763	9,736	10,183	0	0	0
Loss on disposal of assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-119	0	0	0
Financing and debt issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Accretion of debt to fair value
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	50,011	0	0	0
Stock-compensation expense
3,885	3,771	3,773	3,890	4,044	4,302	4,523	4,759	4,983	5,091	5,018	5,128	5,187	5,313	5,515	5,517	5,488	5,413	5,558	5,136	9,737	8,781	0	0	0
Reduction in the carrying amount of operating lease right-of-use assets
-973	-947	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease incentives
-	-	-	-	-	121	122	122	119	111	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Other
-	-	-	-	-	-	-	-	-	1	0	0	0	-	-	-	0	-	-	-	-	-	-	0	0
Changes in operating assets and liabilities:
Accounts receivable
-1,832	6,689	5,823	4,982	5,075	1,723	4,800	4,019	2,971	9,159	-3,034	-8,717	-5,822	-3,089	-3,780	4,721	3,599	2,644	3,282	1,408	3,007	-838	0	0	0
Inventories
4,164	1,450	3,550	277	-706	-1,597	-4,083	-433	-5,158	-3,953	1,090	1,467	8,993	6,336	6,273	5,713	234	1,635	280	585	-1,754	-1,995	0	0	0
Prepaid expenses and other assets
30	84	112	126	-184	-261	-76	-168	-118	-411	-16	-375	488	19	-309	-341	-424	881	787	960	533	129	0	0	0
Accounts payable
118	141	2,002	1,942	1,188	1,557	-1,563	333	-4,309	1,269	-356	-2,626	835	105	-4	1,799	3,496	1,517	1,416	1,947	-199	687	0	0	0
Accrued expenses
-614	4,344	1,075	-586	384	-2,056	-1,236	-130	-227	1,821	763	110	150	-2,178	-1,293	-195	-167	-227	-240	890	434	774	0	0	0
Deferred revenue
1,138	3,392	4,220	7,285	2,548	810	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating lease liabilities
-1,046	-1,018	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other liabilities
-	-56	71	60	48	94	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	0	650	-	-3,762	-2,138	-1,279	333	3,019	1,572	308	-303	0	0	0
Deferred rent
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-
Net cash used in operating activities
604	-1,054	-5,675	-4,350	-9,267	-8,654	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows from investing activities:
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-4,783	-	4,075	788	8,803	5,359	4,636	5,814	2,211	6,648	0	0	0
Capital expenditures
2,402	2,112	2,531	3,238	3,553	3,593	3,346	2,944	4,649	6,118	8,645	10,319	12,234	13,216	12,573	12,725	14,553	21,956	28,008	28,003	22,664	13,241	0	0	0
Net cash used in investing activities
-2,402	-2,112	-2,531	-3,238	-3,553	-3,593	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows from financing activities:
Proceeds from underwritten public offering, net of underwriting discounts and commissions of $1,093
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	0	0	0
Issuance costs from underwritten public offering
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from borrowings under line of credit, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,500	0	0	0
Repayments of borrowings under line of credit, net
0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5,500	0	0	0
Purchase of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,500	0	0	0	-	-	-	-
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-12,234	-	-12,573	-10,221	-12,052	-21,956	-28,008	-30,507	-25,165	-13,241	0	0	0
Prepayment proceeds under customer supply agreement
-	5,000	5,000	5,000	7,500	5,000	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	47	0	0	0
Repayment of obligations under capital lease
-	-	-	-	-	-	-	-	-	27	36	40	52	68	77	85	84	80	77	76	76	80	0	0	0
Payments made for employee restricted stock tax withholdings
1,211	470	483	511	501	551	538	609	609	391	389	404	404	200	0	0	0	-	-	-	-	-	-	-	-
Net cash provided by financing activities
10,215	3,472	4,224	3,624	6,574	4,880	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase in cash
8,417	306	-3,982	-3,964	-6,246	-7,367	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred offering costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Net cash provided by (used in) financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-1,112	-	-337	-405	-404	-318	-305	-2,649	54,809	54,738	0	0	0
Net decrease in cash
-	-	-	-	-	-	-	-	-	-	-	0	-18,129	-	-8,835	-9,838	-3,653	-16,915	-23,687	-27,342	31,855	48,145	0	0	0
Supplemental disclosures of cash flow information:
Interest paid
428	440	434	395	335	338	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid
-	-	-	-	-	-	-	-	-	-	-	-	184	-	202	204	205	198	206	188	206	223	0	0	0
Income taxes paid
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0
Supplemental disclosures of non-cash activities:
Initial recognition of operating lease liabilities related to right-of-use assets
-	5,995	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Right-of-use assets obtained in exchange for new operating lease liabilities
352	353	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unpaid initial public offering costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Changes in accrued capital expenditures
28	63	-789	-309	351	182	561	-346	-2,828	-3,681	-2,187	-1,174	498	2,116	1,382	161	-4,507	-5,332	-6,558	761	6,320	6,401	0	0	0
Capitalized interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	34	0	0	0
Advanced billings
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-